|
(JFL Partners), with respect to the common stock directly and beneficially owned by it; JFL Capital Management LP, a Texas limited partnership (JFL GP), as the general
partner of JFL Partners; JFL Capital Holdings LLC, a Delaware limited liability company (JFL Holdings), as the general partner of JFL GP; JFL Capital Management LLC, a Delaware limited liability company (JFL Capital
Management), as the investment manager of JFL Partners and a certain managed account (the JFL Account); Joseph F. Lawler, M.D., Ph.D., as the Managing Member of each of JFL Holdings and JFL Capital Management; 22NW Fund, LP, a
Delaware limited partnership (22NW Fund), with respect to the common stock directly and beneficially owned by it; 22NW, LP, a Delaware limited partnership (22NW), as the investment manager of 22NW Fund; 22NW Fund GP, LLC, a
Delaware limited liability company (22NW GP), as the general partner of 22NW Fund; 22NW GP, Inc., a Delaware S corporation (22NW Inc.), as the general partner of 22NW; Aron R. English, as the Portfolio Manager of 22NW,
Manager of 22NW GP and President and sole shareholder of 22NW Inc.; Jason M. Aryeh; and Kenneth Lin, M.D. JFL Partners reports that on March 13, 2019, the foregoing reporting persons (other than 22NW Inc.) entered into a Joint Filing and
Solicitation Agreement pursuant to which, among other things, the parties agreed to (a) the joint filing on behalf of each of them of statements on Schedule 13D, and any amendments thereto, with respect to our securities and (b) solicit
proxies for the election of certain director nominees at the 2019 Annual Meeting of Stockholders. JFL Partners reports that on July 24, 2019, 22NW Inc. entered into a Joinder Agreement to the aforementioned Joint Filing and Solicitation
Agreement. The address of the principal office of each of JFL Partners, JFL GP, JFL Holdings, JFL Capital Management and Dr. Lawler is 2110 Ranch Road 620 S, #341732, Lakeway, Texas 78734. The address of the principal office of each of 22NW
Fund, 22NW, 22NW GP, 22NW Inc. and Mr. English is 1455 NW Leary Way, Suite 400, Seattle, Washington 98107. The address of the principal office of Mr. Aryeh is 34 Sumner Road, Greenwich, Connecticut 06831. The address of the principal
office of Dr. Lin is 280 Utah Avenue, Suite 250, South San Francisco, California 94080. As of the close of business on July 24, 2019, JFL Partners directly beneficially owned 510,152 shares of common stock. JFL GP, as the general partner
of JFL Partners, may be deemed to beneficially own the 510,152 shares of common stock owned by JFL Partners. JFL Holdings, as the general partner of JFL GP, may be deemed to beneficially own the 510,152 shares of common stock owned by JFL Partners.
As of the close of business on July 24, 2019, 739,676 shares of common stock were held in the JFL Account. JFL Capital Management, as the investment manager of JFL Partners and the JFL Account, may be deemed to beneficially own the 1,249,828
shares of common stock owned in the aggregate by JFL Partners and held in the JFL Account. Dr. Lawler, as the Managing Member of JFL Capital Management and JFL Holdings, may be deemed to beneficially own the 1,249,828 shares of common stock
owned in the aggregate by JFL Partners and held in the JFL Account. As of the close of business on July 24, 2019, 22NW Fund directly beneficially owned 1,241,896 shares of common stock. 22NW, as the investment manager of 22NW Fund, may be
deemed to beneficially own the 1,241,896 shares of common stock owned by 22NW Fund. 22NW GP, as the general partner of 22NW Fund, may be deemed to beneficially own the 1,241,896 shares of common stock owned by 22NW Fund. 22NW Inc., as the general
partner of 22NW, may be deemed to beneficially own the 1,241,896 shares of common stock owned by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to
beneficially own the 1,241,896 shares of common stock owned by 22NW Fund. As of the close of business on July 24, 2019, Dr. Lin directly beneficially owned 5,000 shares of common stock. As of the close of business on July 24, 2019,
Mr. Aryeh directly beneficially owned 3,802 shares of common stock. Prior to the filing of the September 24, 2019 Schedule 13D/A referenced below, each of the foregoing reporting persons was a member of a group with the other
reporting persons for the purposes of Section 13(d)(3) of the Exchange Act, and such group beneficially owned the 2,500,526 shares of common stock owned in the aggregate by all of the reporting persons. Each such reporting person disclaimed
beneficial ownership of the common stock that he or it does not directly own. Subsequent to August 31, 2019, the reporting persons filed a Schedule 13D/A on September 24, 2019 reporting (i) the termination of the Joint Filing and Solicitation
Agreement and (ii) the entry into a Joint Filing Agreement on September 24, 2019 by JFL Partners, JFL GP, JFL Holdings, JFL Capital Management and Dr. Lawler. By virtue of their respective positions with JFL Partners, each of JFL GP, JFL Holdings,
JFL Capital Management and Dr. Lawler may be deemed to have sole power to vote and dispose of the shares of common stock reported owned by JFL Partners. By virtue of their respective positions with the JFL Account, each of JFL Capital
Management and Dr. Lawler may be deemed to have sole power to vote and dispose of the shares of common stock held in the JFL Account. By virtue of their respective positions with 22NW Fund, each of 22NW, 22NW GP, 22NW Inc. and Mr. English
may be deemed to have sole power to vote and dispose of the shares of common stock reported owned by 22NW Fund. Dr. Lin has the sole power to vote and dispose of the shares of common stock directly beneficially owned by him. Mr. Aryeh has
the sole power to vote and dispose of the shares of common stock directly beneficially owned by him.
|